vs
Side-by-side financial comparison of Healthpeak Properties (DOC) and MATERION Corp (MTRN). Click either name above to swap in a different company.
Healthpeak Properties is the larger business by last-quarter revenue ($702.9M vs $549.8M, roughly 1.3× MATERION Corp). Healthpeak Properties runs the higher net margin — 51.6% vs 3.5%, a 48.1% gap on every dollar of revenue. On growth, MATERION Corp posted the faster year-over-year revenue change (30.8% vs -6.6%). Over the past eight quarters, MATERION Corp's revenue compounded faster (13.6% CAGR vs 0.5%).
Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.
Materion Corp. is a multinational company specializing in high-performance advanced materials. Among its products are advanced beryllium metals, thin film deposition materials, high-performance alloys and composites, specialty engineered beryllium, engineered metals, technical ceramics, tantalum, niobium, other precious and non-precious metals, inorganic chemicals, and specialty coatings.
DOC vs MTRN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $702.9M | $549.8M |
| Net Profit | $363.0M | $19.4M |
| Gross Margin | — | 14.9% |
| Operating Margin | 0.7% | 5.1% |
| Net Margin | 51.6% | 3.5% |
| Revenue YoY | -6.6% | 30.8% |
| Net Profit YoY | 28.3% | 9.5% |
| EPS (diluted) | $0.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $702.9M | $549.8M | ||
| Q4 25 | $719.4M | $489.8M | ||
| Q3 25 | $705.9M | $444.8M | ||
| Q2 25 | $694.3M | $431.7M | ||
| Q1 25 | $702.9M | $420.3M | ||
| Q4 24 | $698.0M | $436.9M | ||
| Q3 24 | $700.4M | $436.7M | ||
| Q2 24 | $695.5M | $425.9M |
| Q1 26 | $363.0M | $19.4M | ||
| Q4 25 | $114.0M | $6.6M | ||
| Q3 25 | $-117.1M | $25.4M | ||
| Q2 25 | $31.7M | $25.1M | ||
| Q1 25 | $42.8M | $17.7M | ||
| Q4 24 | $4.5M | $-48.9M | ||
| Q3 24 | $85.9M | $22.3M | ||
| Q2 24 | $146.0M | $19.0M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | — | 13.0% | ||
| Q3 25 | 58.6% | 19.4% | ||
| Q2 25 | 60.2% | 19.1% | ||
| Q1 25 | 61.1% | 18.1% | ||
| Q4 24 | 60.3% | 21.3% | ||
| Q3 24 | 60.0% | 18.5% | ||
| Q2 24 | 60.6% | 19.0% |
| Q1 26 | 0.7% | 5.1% | ||
| Q4 25 | 17.4% | 2.2% | ||
| Q3 25 | 9.2% | 7.9% | ||
| Q2 25 | 5.7% | 8.5% | ||
| Q1 25 | 7.7% | 6.5% | ||
| Q4 24 | -2.2% | -8.8% | ||
| Q3 24 | 14.1% | 7.2% | ||
| Q2 24 | 22.3% | 7.5% |
| Q1 26 | 51.6% | 3.5% | ||
| Q4 25 | 73.2% | 1.3% | ||
| Q3 25 | -16.6% | 5.7% | ||
| Q2 25 | 4.6% | 5.8% | ||
| Q1 25 | 6.1% | 4.2% | ||
| Q4 24 | 0.7% | -11.2% | ||
| Q3 24 | 12.3% | 5.1% | ||
| Q2 24 | 21.0% | 4.5% |
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $0.30 | ||
| Q3 25 | $-0.17 | $1.22 | ||
| Q2 25 | $0.05 | $1.21 | ||
| Q1 25 | $0.06 | $0.85 | ||
| Q4 24 | $0.02 | $-2.34 | ||
| Q3 24 | $0.12 | $1.07 | ||
| Q2 24 | $0.21 | $0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $-1.2B | $16.2M |
| Total DebtLower is stronger | — | $489.9M |
| Stockholders' EquityBook value | $7.8B | $957.0M |
| Total Assets | $21.6B | $1.9B |
| Debt / EquityLower = less leverage | — | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-1.2B | $16.2M | ||
| Q4 25 | $467.5M | $13.7M | ||
| Q3 25 | $91.0M | $16.4M | ||
| Q2 25 | $89.4M | $12.6M | ||
| Q1 25 | $70.6M | $15.6M | ||
| Q4 24 | $119.8M | $16.7M | ||
| Q3 24 | $180.4M | $17.9M | ||
| Q2 24 | $106.9M | $17.1M |
| Q1 26 | — | $489.9M | ||
| Q4 25 | $9.8B | $460.6M | ||
| Q3 25 | $9.1B | $458.9M | ||
| Q2 25 | $9.0B | $427.6M | ||
| Q1 25 | $8.9B | $453.0M | ||
| Q4 24 | $8.7B | $443.9M | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — |
| Q1 26 | $7.8B | $957.0M | ||
| Q4 25 | $7.5B | $943.3M | ||
| Q3 25 | $7.6B | $934.6M | ||
| Q2 25 | $7.9B | $910.6M | ||
| Q1 25 | $8.2B | $887.9M | ||
| Q4 24 | $8.4B | $868.9M | ||
| Q3 24 | $8.6B | $931.9M | ||
| Q2 24 | $8.8B | $907.1M |
| Q1 26 | $21.6B | $1.9B | ||
| Q4 25 | $20.3B | $1.8B | ||
| Q3 25 | $19.6B | $1.8B | ||
| Q2 25 | $19.8B | $1.7B | ||
| Q1 25 | $19.8B | $1.8B | ||
| Q4 24 | $19.9B | $1.7B | ||
| Q3 24 | $20.0B | $1.9B | ||
| Q2 24 | $20.2B | $1.8B |
| Q1 26 | — | 0.51× | ||
| Q4 25 | 1.31× | 0.49× | ||
| Q3 25 | 1.20× | 0.49× | ||
| Q2 25 | 1.14× | 0.47× | ||
| Q1 25 | 1.08× | 0.51× | ||
| Q4 24 | 1.04× | 0.51× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
MTRN
Segment breakdown not available.
